Time to rewrite AIDS vaccine playbook

The head of the International AIDS Vaccine Initiative, Seth Berkley, wants to rewrite the playbook for developing an effective AIDS vaccine. Out: The disastrous Merck approach to spur cell-based immunity. In: Recruiting antibodies to neutralize the virus. The Wall Street Journal notes that four antibodies have been identified by a research consortium as potentially up to the task while Berkley believes the list could be as high as 15. Report

Suggested Articles

AstraZeneca is picking up a delayed preclinical fibrosis candidate from RedX in a deal that gives the U.K. biotech a much needed cash boost.

Data from a 10,000-patient trial showed that people with osteoarthritis taking Novartis' Ilaris had 40% to 47% lower rates of joint replacements.

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.